Development and validation of the ASGARD risk score for safe monitoring in asymptomatic nonsevere aortic stenosis

Edina Hadziselimovic*, Anders M Greve, Ahmad Sajadieh, Michael H Olsen, Christoph A Nienaber, Simon G Ray, Anne B Rossebø, Kristian Wachtell, Helena Dominguez, Nana Valeur, Helle G Carstensen, Olav W Nielsen

*Corresponding author for this work

Abstract

AIMS: Current guidelines recommend serial echocardiography at minimum 1-2 year intervals for monitoring patients with nonsevere aortic valve stenosis (AS), which is costly and often clinically inconsequential.We aimed to develop and test whether the biomarker-based ASGARD risk score (Aortic Valve Stenosis Guarded by Amplified Risk Determination) can guide the timing of echocardiograms in asymptomatic patients with nonsevere AS.

METHODS: The development cohort comprised 1,093 of 1,589 (69%) asymptomatic patients with mild-to-moderate AS who remained event-free one year after inclusion into the SEAS trial. Cox regression landmark analyses with a 2-year follow-up identified the model (ASGARD) with the lowest Akaike information criterion for association to AS-related composite outcome (heart failure hospitalization, aortic valve replacement, or cardiovascular death). Fine-Gray analyses provided cumulative event rates by ASGARD score quartiles. The ASGARD score was internally validated in the remaining 496 patients (31%) from the SEAS-cohort and externally in 71 asymptomatic outpatients with nonsevere AS from six Copenhagen hospitals.

RESULTS: The ASGARD score comprises updated measurements of heart rate and age- and sex-adjusted N-terminal pro-brain natriuretic peptide upon transaortic maximal velocity (Vmax) from the previous year. The ASGARD score had high predictive accuracy across all cohorts (external validation: area under the curve: 0.74 [95% CI, 0.62-0.86]), and similar to an updated Vmax measurement. An ASGARD score ≤50% was associated with AS-related event rates ≤5% for a minimum of 15 months.

CONCLUSION: The ASGARD score could provide a personalized and safe surveillance alternative to routinely planned echocardiograms, so physicians can prioritize echocardiograms for high-risk patients.

Original languageEnglish
JournalEuropean Journal of Preventive Cardiology
ISSN2047-4873
DOIs
Publication statusE-pub ahead of print - 28 Feb 2024

Fingerprint

Dive into the research topics of 'Development and validation of the ASGARD risk score for safe monitoring in asymptomatic nonsevere aortic stenosis'. Together they form a unique fingerprint.

Cite this